Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Concomitant ablation of atrial fibrillation in octogenarians: an observational study

  • Herko Grubitzsch1Email author,
  • Sven Beholz1,
  • Pascal M Dohmen1,
  • Simon Dushe1 and
  • Wolfgang Konertz1
Journal of Cardiothoracic Surgery20083:21

DOI: 10.1186/1749-8090-3-21

Received: 19 June 2007

Accepted: 29 April 2008

Published: 29 April 2008

Abstract

Background

Cardiac surgery is increasingly required in octogenarians. These patients frequently present atrial fibrillation (AF), a significant factor for stroke and premature death. During the last decade, AF ablation has become an effective procedure in cardiac surgery. Because the results of concomitant AF ablation in octogenarians undergoing cardiac surgery are still not clear, we evaluated the outcome in these patients.

Methods

Among 200 patients undergoing concomitant AF ablation (87% persistent AF), 28 patients were ≥ 80 years (82 ± 2.4 years). The outcome was analysed by prospective follow up after 3, 6, 12 months and annually thereafter. Freedom from AF was calculated according to the Kaplan-Meier method.

Results

Octogenarians were similar to controls regarding AF duration (48 ± 63.2 versus 63 ± 86.3 months, n.s.) and left atrial diameter (49 ± 6.1 versus 49 ± 8.8 mm, n.s.), but differed in EuroSCORE (17.3 ± 10.93 versus 7.4 ± 7.31%, p < 0.001), prevalence of paroxysmal AF (25.0 versus 11.0%, p = 0.042) and aortic valve disease (67.8 versus 28.5%, p < 0.001). ICU stay (8 ± 16.9 versus 4 ± 7.2 days, p = 0.027), hospital stay (20 ± 23.9 versus 14 ± 30.8 days, p < 0.05), and 30-d-mortality (14.3 versus 4.6%, p = 0.046) were increased. After 12 ± 6.1 months of follow-up (95% complete), 14 octogenarians (82%) and 101 controls (68%, n.s.) were in sinus rhythm; 59% without antiarrhythmic drugs in either group (n.s.). Sinus rhythm restoration was associated with improved NYHA functional class and renormalization of left atrial size. Cumulative freedom from AF demonstrated no difference between groups. Late mortality was higher in octogenarians (16.7 versus 6.1%, p = 0.065).

Conclusion

Sinus rhythm restoration rate and functional improvement are satisfactory in octogenarians undergoing concomitant AF ablation. Hence, despite an increased perioperative risk, this procedure should be considered even in advanced age.

Background

Because industrialized countries are experiencing an aging population, the age of patients necessitating cardiac surgery is steadily rising. According to the registry of the German Society for Thoracic and Cardiovascular Surgery, more than 8.4% of patients undergoing cardiac surgical procedures in 2005 were older than 80 years, compared to 2.7% ten years ago [1]. It was shown that these high risk elderly patients derive benefit from coronary revascularization, aortic as well as mitral valve surgery, and combined procedures [24].

Atrial fibrillation (AF), a significant factor for stroke and premature death, is the most frequent sustained atrial arrhythmia [5]. Because its incidence increases with age, a growing number of patients scheduled for valvular or coronary heart surgery, nowadays present AF [6, 7]. During the last decade, surgical AF treatment, initially introduced as Maze procedure [8, 9], has been developed to a less complex operation by using different technologies for tissue ablation and by focussing the lesion pattern on the left atrium [7, 10, 11]. AF ablation has become a frequently performed concomitant procedure in cardiac surgery with overall promising results regarding sinus rhythm (SR) restoration [7, 10].

Because the results of surgical AF treatment in octogenarians are not clear, we evaluated outcome of these patients undergoing cardiac surgery and concomitant AF ablation.

Methods

Patients

Between January 2003 and February 2006, a total of 200 patients (54.5% male) scheduled for cardiac surgery underwent concomitant AF ablation. The majority of patients presented with persistent/continuous AF (n = 174, 87.0%) according to established definitions [12, 13]. Out of all, 28 patients aged 80 years and older were summarized as group of octogenarians. According to age (< 80 years versus ≥ 80 years), patients were prospectively studied. Preoperative, perioperative and follow up data were entered into an institutional database. Informed consent regarding the operation and data acquisition was obtained from all patients. For assessment of perioperative risk, logistic EuroSCORE was determined [14].

Surgical procedures and perioperative treatment

The detailed procedures of the study population are listed in Table 1. For all procedures, standard normothermic cardiopulmonary bypass and warm antegrade blood cardioplegia were used. All patients underwent endocardial ablation of the left atrium as described in detail previously [7]. The left atrial appendage was oversewn only if thrombi were inside (n = 4).
Table 1

Surgical procedures

 

Overall (n = 200) % (n)

Age < 80 yrs (n = 172) % (n)

Age ≥ 80 yrs (n = 28) % (n)

MVP/-R

37.5 (75)

41.3 (71)

14.3 (4)

   isolated

57.3 (43)

59.2 (42)

25.0 (1)

   + CABG

28.0 (21)

25.4 (18)

75.0 (3)

   + TVP/R/+ CABG/+ congenital

14.7 (11)

15.5 (11)

-

AVR

34.0 (68)

28.5 (49)

67.8 (19)

   isolated

58.8 (40)

61.2 (30)

52.6 (10)

   + CABG

11.8 (8)

6.1 (3)

26.3 (5)

   + MVP/-R/+ TVP/-R/+ CABG/+ AAR

29.4 (20)

32.6(16)

21.1 (4)

CABG

28.0 (56)

29.6 (51)

17.8 (5)

   isolated

98.2 (55)

98.0 (50)

100 (5)

   + aneurysmectomy

1.8 (1)

2.0 (1)

-

other procedures

0.5 (1)

0.6 (1)

-

LA reduction plasty

1.5 (3)

1.7 (3)

-

reoperation

7.0 (14)

7.6 (13)

3.6 (1)

microwave ablation

53.5 (107)

52.9 (91)

57.1 (16)

radiofrequency ablation

46.5 (93)

47.1 (81)

42.8 (12)

AAR, ascending aortic replacement, AVR, aortic valve replacement; CABG, coronary artery bypass grafting; MVP/-R, mitral valve plasty/replacement; TVP/R, tricuspid valve plasty/replacement; yrs, years

All patients were anticoagulated with heparin followed by phenprocoumon with a target INR of 2.0–3.0. After 3 months and stable sinus or atrial driven pacemaker rhythm in Holter ECG and mechanical atrial function in echocardiogram anticoagulation was ceased. Patients with mechanical valve substitutes were kept on phenprocoumon permanently (INR of 2.5–3.5 for aortic and 3.0–4.0 for mitral valve prostheses). DC shock cardioversion of early recurrent AF was performed if patient was symptomatic or hemodynamically compromised. Perioperatively, either patient's preoperative betablocker was continued or antiarrhythmic treatment with class III antiarrhythmic drugs (sotalol or amiodarone) was initiated. The decision was left to the discretion of the surgeon. After discharge, patient's general physician or cardiologist managed the anticoagulation and antiarrhythmic therapy.

Follow up

Prospective follow up (FU) was performed after 3, 6, 12 months and annually thereafter. Patients were interviewed and underwent clinical examination, electrocardiography, and transthoracic echocardiography (TTE). Only in 9 patients (4.8%), who were not able to visit the clinic, interviewing was done by telephone and echocardiographic data were obtained from the referring cardiologist. Ablation was considered successful if SR was maintained with no symptomatic or documented episodes of AF or atrial flutter. Any regular atrial driven rhythm, including atrial (n = 1), atrioventricular (n = 3), or atrial triggered ventricular (n = 5) pacing, was regarded as sinus rhythm (SR).

Echocardiography

Preoperatively, before discharge and at FU, all patients underwent TTE using the HP Sonos 5500 (Hewlett Packard, Andover, Massachusetts, USA). LA and LV diameter were measured using standard techniques. LVEF was assessed by the Simpson method. For assessment of LA function the pulsed-wave signal of diastolic transmitral flow was used. Maximal flow velocities of E and A waves were measured and E/A ratio was calculated.

Statistical analysis

Unless otherwise indicated, data are presented as mean ± standard deviation or absolute and relative frequencies. For comparison between groups, Mann-Whitney's U-test (continuous variables) and Fisher's exact test (categorical variables) were used. For comparison of FU and preoperative data within groups Wilcoxon's rank-sum test was applied. All tests of significance were two-tailed and a value of p < 0.05 was considered significant. During FU, freedom from AF was calculated according to the Kaplan-Meier method. Differences were analysed by log-rank test. Statistical analysis was performed using a statistical software program (SPSS 13.0 for Windows, SPSS Inc., Chicago, Illinois, USA).

Results

Patient groups

The mean age of octogenarians was 82 ± 2.4 years (range 80–89 years), whereas the mean age of younger patients was significantly lower at 68 ± 7.9 years (range 40–79 years). Baseline characteristics are presented in Table 2. There was a higher proportion of women in octogenarians which was associated with a lower body surface area. The pattern of valvular heart disease was significantly different in both groups with respectively higher incidence of mitral valve disease in younger and aortic valve disease in older patients. There was a non-significant trend to an increased percentage of patients with a history of thrombembolic events in octogenarians. AF duration and LA size, two important AF criteria, were similar in either group, although a higher proportion of younger patients were in persistent AF. According to New York Heart Association (NYHA) functional class and EuroSCORE, older patients were significantly more compromised and exhibited a higher perioperative risk.
Table 2

Baseline data

  

Age < 80 yrs (n = 172)

Age ≥ 80 yrs (n = 28)

p

male gender

% (n)

57.6 (99)

35.7 (10)

0.031

body surface area

m2

1.9 ± 0.22

1.8 ± 0.18

0.003

coronary artery disease

% (n)

45.3 (78)

50.0 (14)

0.647

mitral valve disease

% (n)

50.0 (86)

28.6 (8)

0.035

aortic valve disease

% (n)

28.5 (49)

67.8 (19)

< 0.001

others

% (n)

9.3 (16)

-

-

previous embolism

% (n)

1.7 (3)

7.1 (2)

0.089

persistent AF

% (n)

89.0 (153)

75.0 (21)

0.042

AF duration

months

63 ± 86.3

48 ± 63.2

0.400

LA diameter

mm

49 ± 8.8

49 ± 6.1

0.954

LVEF

 

0.51 ± 0.013

0.52 ± 0.014

0.656

LVEDD

mm

54 ± 8.1

49 ± 10.4

0.379

NYHA class

 

2.9 ± 0.81

3.4 ± 0.67

0.021

logistic EuroSCORE

%

7.4 ± 7.31

17.3 ± 10.93

< 0.001

AF, atrial fibrillation; LA, left atrial; LVEDD, left ventricular enddiastolic diameter; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; yrs, years

Procedural outcome

In octogenarians and younger patients, there was no difference in aortic cross clamp time (90 ± 29.2 and 85 ± 32.0 min, p = 0.464), cardiopulmonary bypass time (125 ± 31.9 and 116 ± 38.5 min, p = 0.568), and operation time (206 ± 41.0 and 217 ± 60.0 min, p = 0.389). Post ablation treatment with antiarrhythmic drugs or betablockers was similar in both groups (Table 3). In 6 patients, a dual chamber pacemaker was implanted due to sinus node dysfunction. Regarding perioperative morbidity, the incidence of heart failure requiring intraaortic balloon pump support and the incidence of renal failure was significantly higher in octogenarians. All patients of this group who acquired infections early after operation developed sepsis. The incidence of cerebral ischemic events was similar in younger and older patients. Overall, 2 strokes (on postoperative day [POD] 1 and 5), and 2 transient neurological deficits (on POD 2 and 6) occurred. Multiple thrombembolism due to hereditary thrombotic thrombocytopenic purpura occurred in one of these patients on POD 5. Apart from a trend to prolonged mechanical ventilation, older age was associated with significantly longer ICU and hospital stay. Perioperative mortality was higher in octogenarians. No death was ablation related.
Table 3

Perioperative data

  

Age < 80 yrs (n = 172)

Age ≥ 80 yrs (n = 28)

p

betablocker

% (n)

27.9 (48)

17.8 (5)

0.172

class III antiarrhythmic drugs

% (n)

52.3 (90)

60.7 (17)

0.409

   Sotalol

% (n)

76.7 (69)

58.8 (10)

0.125

   Amiodaron

% (n)

23.3 (21)

41.2 (7)

0.125

DC shock cardioversion

% (n)

4.6 (8)

3.6 (1)

0.798

pacemaker implantation

% (n)

3.5 (6)

-

-

re-exploration for bleeding

% (n)

2.3 (4)

-

-

pericardial effusion

% (n)

1.2 (2)

-

-

heart failure

% (n)

4.1 (7)

7.1 (2)

0.467

   inotropic support

% (n)

4.1 (7)

7.1 (2)

0.467

   IABP

% (n)

2.9 (5)

5.1 (4)

0.045

   LVAD

% (n)

1.2 (2)

-

-

pulmonary failure

% (n)

-

3.6 (1)

-

renal failure

% (n)

7.0 (12)

17.8 (5)

0.056

cerebrovascular accident

% (n)

1.7 (3)

3.6 (1)

0.522

intracerebral hemorrhage

% (n)

0.6 (1)

-

-

infection

% (n)

4.6 (8)

10.7 (3)

0.192

   mediastinitis

% (n)

0.6 (1)

3.6 (1)

0.140

   bronchopulmonary infection

% (n)

4.1 (7)

7.1 (2)

0.467

   sepsis

% (n)

2.3 (4)

10.7 (3)

0.025

mechanical ventilation time

hrs

21 ± 50.3

28 ± 41.1

0.069

ICU stay

days

4 ± 7.2

8 ± 16.9

0.027

hospital stay

days

14 ± 30.8

20 ± 23.9

0.004

mortality (30 days)

% (n)

4.6 (8)

14.3 (4)

0.046

cardiac death

% (n)

0.6 (1)

3.6 (1)

0.140

non-cardiac death

% (n)

4.1 (7)

10.7 (3)

0.135

DC, direct current; IABP, intraaortic balloon pump; ICU, intensive care unit; LVAD, left ventricular assist device; yrs, years

Outcome during follow up

Mean FU after 12 ± 6.1 months was 95% complete; 9 patients were lost. During FU, mortality was higher in octogenarians (16.7% versus 6.1%, p = 0.065). Causes of late death were cardiac in 3 and 1, non-cardiac in 6 and 2, and unknown in either 1 younger and older patients, respectively. In neither group, thrombembolic complications occurred. Compared to discharge, there was a trend to higher SR conversion rate after 6 and 12 months (Figure 1). Neither between cohorts, nor at different FU visits, statistical significance was reached. Results regarding rhythm outcome are outlined in Table 4. At latest available FU, 14 octogenarians (82%) and 101 younger patients (68%, p = 0.231) were in sinus rhythm (SR); 59% without antiarrhythmic drugs in either group (p = 0.997). Recurrent tachyarrhythmia was successfully treated by DC shock cardioversion in 3 patients aged < 80 years and 1 patient ≥ 80 years and by interventional ablation in 2 younger patients. The majority of patients in SR presented normal atrial contraction (Table 4). Compared to patients who were not in SR, patients with restored SR at FU presented smaller LA size (41 ± 5.3 versus 45 ± 7.3 mm, p = 0.005 and 41 ± 8.8 versus 46 ± 11.6 mm, p = 0.498) and better NYHA functional class (1.8 ± 0.60 versus 2.2 ± 0.56, p < 0.001 and 1.9 ± 0.48 versus 2.3 ± 0.58, p = 0.203) in younger and older age group, respectively. According to LVEF, left ventricular function remained unchanged in either group. Kaplan-Meier estimates of freedom from persistent AF demonstrated no difference between both groups (Figure 2).
Table 4

Outcome at last follow up

  

Age < 80 yrs (n = 148)

Age ≥ 80 yrs (n = 17)

p

sinus rhythm

% (n)

68.2 (101)

82.3 (14)

0.231

   atrial contraction

% (n)

87.8 (79)

100 (12)

0.200

   E/A ratio

 

2.5 ± 0.83

2.1 ± 0.75

0.179

atrial fibrillation

% (n)

26.3 (39)

11.8 (2)

0.187

atrial flutter

% (n)

3.4 (5)

5.9 (1)

0.601

NYHA class

 

1.9 ± 0.61*

2.1 ± 0.57*

0.304

LA diameter

mm

42 ± 6.3*

42 ± 9.1*

0.952

LVEF

 

0.52 ± 0.120

0.55 ± 0.091*

0.358

LVEDD

mm

54 ± 9.4

49 ± 8.3

0.048

*p < 0.001, comparison to preoperative data by Wilcoxon rank-sum test

p = n.s., comparison to preoperative data by Wilcoxon rank-sum test

E/A ratio, ratio of maximal flow velocities of early (E) and atrial (A) diastolic transmitral flow signal assessed by pulsed-wave Doppler; NYHA, New York Heart Association; LA, left atrial; LVEF, left ventricular ejection fraction; LVEDD, left ventricular enddiastolic diameter

Assessment of LA function by pulsed wave Doppler failed in 11 and 2 patients in the younger and older age group, respectively.

https://static-content.springer.com/image/art%3A10.1186%2F1749-8090-3-21/MediaObjects/13019_2007_Article_121_Fig1_HTML.jpg
Figure 1

Sinus rhythm at follow up. Figures in bars indicate absolute frequencies of patients in SR.

https://static-content.springer.com/image/art%3A10.1186%2F1749-8090-3-21/MediaObjects/13019_2007_Article_121_Fig2_HTML.jpg
Figure 2

Kaplan-Meier estimates. Freedom from persistent AF in patients </≥ 80 years. AF, atrial fibrillation; yrs, years.

Discussion

A constant extension of life expectancy in industrialized countries together with an increased incidence of cardiovascular disease is leading to a rising number of elderly patients referred for cardiac surgery. These patients frequently present with AF, because the prevalence of this arrhythmia is exponentially age-related [6]. Whereas AF occurs in less than 0.5% of patients younger than 60 years, approximately 10% of patients older than 80 years are in AF [6]. Because promising results have been reported on valvular and coronary surgery in octogenarians [24], we evaluated the outcome of patients in this age group after concomitant AF ablation.

In this study, octogenarians were different from younger controls in that they were more likely to be female and require aortic valve replacement. Either distribution refers to demographic characteristics and is consistent with previous reports [15, 16]. On the other hand, the underlying heart disease does not determine results of AF ablation [7]. The observed inferior functional status according to NYHA class and the trend to higher incidence of preoperative thrombembolic events may reflect general findings in advanced age [2]. As age is one of the most important predictors for operative mortality [14], patients ≥ 80 years exhibited a significantly higher risk reflected by EuroSCORE. According to recent reports, early mortality after cardiac surgery in octogenarians ranges from 7.5% to 26.5% (table 5). Apart from age, NYHA functional class [3, 17, 18], presence of heart failure as well as left ventricular dysfunction [3, 15], pulmonary hypertension [17], and renal insufficiency [3, 19] were demonstrated to be predictive factors for mortality. Furthermore, procedural factors as urgent/emergency and re-do surgery [3, 4, 1820] or combined valvular plus revascularization surgery [4] increase operative risk. In this study, patients ≥ 80 years who died early after operation were characterized by LVEF ≤ 0.40 (n = 2), re-do surgery (n = 1), and other than isolated CABG (n = 4) resulting in a mean logistic EuroSCORE of 25.6%. Interestingly, causes of death were mainly non-cardiac. As reported very recently, AF per se seems to be a marker for higher operative risk [21, 22]. However, the particular impact of AF ablation on perioperative mortality has not been clarified, yet. Analysis of overall complications early after operation (table 3) reflects the fragility of octogenarians due to age-related alterations in different organ systems. As in our patients for instance, renal failure frequently occurs after cardiac surgery in octogenarians [2, 19] and contributes to operative risk [20]. In contrast to others [2, 19, 20], we did not observe an increase in postoperative stroke in our small cohort of patients. With respect to mechanical ventilation time, length of ICU and hospital stay, and incidence of postoperative complications, increased resource utilization has to be considered in octogenarians undergoing cardiac surgery [2].
Table 5

Outcome of octogenarians undergoing cardiac surgery

 

procedure

author

year

n

operative mortality

longterm survival

      

1 year

5 years

CABG

isolated

Alexander [19]

2000

4306

8.1% (hospital)

-

-

 

isolated

Kolh [18]

2001

70

10.0% (hospital)

-

65.8%

 

isolated

Scott [2]

2005

155

9.0% (30 days)

-

-

AVR

combined

Alexander [19]

2000

345

10.1% (hospital)

-

-

 

isolated and combined

Sundt [20]

2000

133

11.0% (30 days)

80.0%

55.0%

 

isolated

Kolh [18]

2001

70

8.5% (hospital)

-

63.6%

 

combined

Kolh [18]

2001

30

26.5% (hospital)

-

62.4%

 

isolated and combined

Chiappini [23]

2004

115

8.5% (hospital)

86.4%

69.4%

 

isolated and combined

Langanay [3]

2006

442

7.5%

-

-

MVP-/R

combined

Alexander [19]

2000

92

19.7% (hospital)

-

-

 

isolated

Kolh [18]

2001

12

25.0% (hospital)

 

57.1%

 

isolated and combined

Nagendran [4]

2005

58

15.5% (hospital)

-

70.0%

AVR, aortic valve replacement; CABG, coronary artery bypass grafting; MVP-/R, mitral valve plasty/replacement

Overall survival of 82% after mean FU of 12 months was comparable with outcome after isolated or combined aortic valve replacement (table 5) [20, 23]. As AF prevalence is high in patients older than 80 years [6], it seems obvious that advanced age predicted recurrent AF after the Cox Maze procedure in mitral valve disease [24]. Nonetheless, we found, that SR can be restored in the majority of elderly patients leading to normal atrial contraction and symptomatic improvement regarding NYHA functional class. Although octogenarians more frequently presented with paroxysmal AF at baseline, 71.4% of patients ≥ 80 years with persistent AF before operation were in SR at last FU. Moreover, freedom from AF during FU was not different in octogenarians and younger patients (figure 2). The overall SR conversion rate observed in this study is within the range of 57–92%, reported in a recent metaanalysis [25]. At least in part, this could be attributed to the left atrial in contrast to the classical biatrial approach. However, a less complex procedure for concomitant AF treatment might be beneficial, in particular for octogenarians. Furthermore, it was shown that AF will not recur if macro-reentry can be prevented by lesions critically placed in the left atrium [11, 13].

Conclusion

This is the first report on concomitant AF ablation in octogenarians undergoing cardiac surgery. The main finding is, that SR and atrial transport function could be restored in the majority of patients. Certainly, ongoing research has to prove these results in larger cohorts and during long-term follow up. Because this study is a retrospective analysis of prospectively collected data it suffers from general limitations inherent to observational studies in non-randomized patient groups. Hence, we are unable to generalize our results to all patients ≥ 80 years with AF necessitating cardiac surgery. Preoperative identification of candidates in whom concomitant AF ablation will improve outcome is indeed challenging, especially if perioperative risk and a certain percentage of patients remaining in AF are considered. Nevertheless, our finding suggests integration of concomitant AF ablation as reasonable treatment strategy in elderly patients with AF referred for cardiac surgery.

List of abbreviations used

AAR: 

ascending aortic replacement

AF: 

atrial fibrillation

AVR: 

aortic valve replacement

CABG: 

coronary artery bypass grafting

DC: 

direct current

ECG: 

electrocardiogram

FU: 

follow up

IABP: 

intraaortic balloon pump

ICU: 

intensive care unit

INR: 

international normalized ratio

LA: 

left atrial

LV: 

left ventricular

LVAD: 

left ventricular assist device

LVEDD: 

left ventricular enddiastolic diameter

LVEF: 

left ventricular ejection fraction

MVP/-R: 

mitral valve plasty/replacement

n.s.: 

not significant

NYHA: 

New York Heart Association

POD: 

postoperative day

SR: 

sinus rhythm

TTE: 

transthoracic echocardiography

TVP/R: 

tricuspid valve plasty/replacement

Yrs: 

years

Declarations

Acknowledgements

We are thankful to Mrs. Doreen Boettner for excellent coordination of patients follow up.

Authors’ Affiliations

(1)
Department of Cardiovascular Surgery, Charité – Universitätsmedizin Berlin, Campus Charité Mitte

References

  1. Gummert JF, Funkat A, Beckmann A, Hekmat K, Ernst M, Krian A: Cardiac surgery in Germany 2005: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg. 2006, 54: 362-371. 10.1055/s-2006-924405.View ArticlePubMedGoogle Scholar
  2. Scott BH, Seifert FC, Grimson R, Glass PS: Octogenarians undergoing coronary artery bypass graft surgery: resource utilization, postoperative mortality, and morbidity. J Cardiothorac Vasc Anesth. 2005, 19: 583-588. 10.1053/j.jvca.2005.03.030.View ArticlePubMedGoogle Scholar
  3. Langanay T, Verhoye JP, Ocampo G, Vola M, Tauran A, De La Tour B, Derieux T, Ingels A, Corbineau H, Leguerrier A: Current hospital mortality of aortic valve replacement in octogenarians. J Heart Valve Dis. 2006, 15: 630-637.PubMedGoogle Scholar
  4. Nagendran J, Norris C, Maitland A, Koshal A, Ross DB: Is mitral valve surgery safe in octogenarians?. Eur J Cardiothorac Surg. 2005, 28: 83-87. 10.1016/j.ejcts.2004.12.067.View ArticlePubMedGoogle Scholar
  5. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D: Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation. 1998, 98: 946-952.View ArticlePubMedGoogle Scholar
  6. Kannel WB, Wolf PA, Benjamin EJ, Levy D: Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998, 82: 2N-9N. 10.1016/S0002-9149(98)00583-9.View ArticlePubMedGoogle Scholar
  7. Grubitzsch H, Beholz S, Dohmen PM, Dushe S, Liu J, Konertz W: Ablation of atrial fibrillation in valvular heart surgery: are results determined by underlying valve disease?. J Heart Valve Dis. 2007, 16: 76-83.PubMedGoogle Scholar
  8. Cox JL, Schuessler RB, D'Agostino HJ, Stone CM, Chang BC, Cain ME, Corr PB, Boineau JP: The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg. 1991, 101: 569-583.PubMedGoogle Scholar
  9. Cox JL, Jaquiss RDB, Schuessler RB, Boineau JP: Modification of the Maze procedure for atrial flutter and atrial fibrillation. II. Surgical technique of the Maze III procedure. J Thorac Cardiovasc Surg. 1995, 110: 485-495. 10.1016/S0022-5223(95)70245-8.View ArticlePubMedGoogle Scholar
  10. Khargi K, Deneke T, Haardt H, Lemke B, Grewe P, Müller KM, Laczkovics A: Saline-irrigated, cooled-tip radiofrequency ablation is an effective technique to perform the Maze procedure; a prospective randomised study. Ann Thorac Surg. 2001, 72: 1090-1095. 10.1016/S0003-4975(01)02940-X.View ArticleGoogle Scholar
  11. Kottkamp H, Hindricks G, Hammel D, Autschbach R, Mergenthaler J, Borggrefe M, Breithardt G, Mohr FW, Scheld HH: Intraoperative radiofrequency ablation of chronic atrial fibrillation: a left atrial curative approach by elimination of anatomic anchor reentrant circuits. J Cardiovasc Electrophysiol. 1999, 10: 772-780. 10.1111/j.1540-8167.1999.tb00256.x.View ArticlePubMedGoogle Scholar
  12. Fuster V, Rydén LE, Cannom DS: ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. J Am Coll Cardiol. 2006, 48: e149-246. 10.1016/j.jacc.2006.07.018.View ArticleGoogle Scholar
  13. Cox JL: Surgical treatment of atrial fibrillation: a review. Europace. 2004, 5: S20-S29. 10.1016/j.eupc.2004.07.004.View ArticlePubMedGoogle Scholar
  14. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R: European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999, 16: 9-13. 10.1016/S1010-7940(99)00134-7.View ArticlePubMedGoogle Scholar
  15. Collart F, Feier H, Kerbaul F, Mouly-Bandini A, Riberi A, Mesana TG, Metras D: Valvular surgery in octogenarians: operative risk factors, evaluation of Euroscore and long term results. Eur J Cardiothorac Surg. 2005, 27: 276-280. 10.1016/j.ejcts.2004.10.041.View ArticlePubMedGoogle Scholar
  16. Stoica SC, Cafferty F, Kitcat J, Baskett RJ, Goddard M, Sharples LD, Wells FC, Nashef SA: Octogenarians undergoing cardiac surgery outlive their peers: a case for early referral. Heart. 2006, 92: 503-506. 10.1136/hrt.2005.064451.View ArticlePubMedGoogle Scholar
  17. Kirsch M, Guesnier L, LeBesnerais P, Hillion ML, Debauchez M, Seguin J, Loisance DY: Cardiac operations in octogenarians: perioperative risk factors for death and impaired autonomy. Ann Thorac Surg. 1998, 66: 60-67. 10.1016/S0003-4975(98)00360-9.View ArticlePubMedGoogle Scholar
  18. Kolh P, Kerzmann A, Lahaye L, Gerard P, Limet R: Cardiac surgery in octogenarians: perioperative outcome and long-term results. Eur Heart J. 2001, 22: 1159-1161. 10.1053/euhj.2000.2443.View ArticleGoogle Scholar
  19. Alexander KP, Anstrom KJ, Muhlbaier LH, Grosswald RD, Smith PK, Jones RH, Peterson ED: Outcomes of cardiac surgery in patients > or = 80 years: results from the national cardiovascular network. J Am Coll Cardiol. 2000, 35: 731-738. 10.1016/S0735-1097(99)00606-3.View ArticlePubMedGoogle Scholar
  20. Sundt TM, Bailey MS, Moon MR, Mendeloff EN, Huddleston CB, Pasque MK, Barner HB, Gay WA: Quality of life after aortic valve replacement at the age of > 80 years. Circulation. 2000, 102 (Suppl 3): III70-74.PubMedGoogle Scholar
  21. Quader MA, McCarthy PM, Gillinov AM, Alster JM, Cosgrove DM, Lytle BW, Blackstone EH: Does preoperative atrial fibrillation reduce survival after coronary artery bypass grafting?. Ann Thorac Surg. 2004, 77: 1514-1524. 10.1016/j.athoracsur.2003.09.069.View ArticlePubMedGoogle Scholar
  22. Levy F, Garayalde E, Quere JP, Ianetta-Peltier M, Peltier M, Tribouilloy C: Prognostic value of preoperative atrial fibrillation in patients with aortic stenosis and low ejection fraction having aortic valve replacement. Am J Cardiol. 2006, 98: 809-811. 10.1016/j.amjcard.2006.03.067.View ArticlePubMedGoogle Scholar
  23. Chiappini B, Camurri N, Loforte A, Di Marco L, Di Bartolomeo R, Marinelli G: Outcome after aortic valve replacement in octogenarians. Ann Thorac Surg. 2004, 78: 85-89. 10.1016/j.athoracsur.2003.12.060.View ArticlePubMedGoogle Scholar
  24. Gillinov AM, Sirak J, Blackstone EH, McCarthy PM, Rajeswaran J, Pettersson G, Sabik FJ, Svensson LG, Navia JL, Cosgrove DM, Marrouche N, Natale A: The Cox maze procedure in mitral valve disease: predictors of recurrent atrial fibrillation. J Thorac Cardiovasc Surg. 2005, 130: 1653-60. 10.1016/j.jtcvs.2005.07.028.View ArticlePubMedGoogle Scholar
  25. Khargi K, Hutten BA, Lemke B, Deneke T: Surgical treatment of atrial fibrillation; a systematic review. Eur J Cardiothorac Surg. 2005, 27: 258-265. 10.1016/j.ejcts.2004.11.003.View ArticlePubMedGoogle Scholar

Copyright

© Grubitzsch et al; licensee BioMed Central Ltd. 2008

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement